Skip to main content
White House budget would boost FDA's ability to respond to opioid crisis

The White House's budget request for fiscal 2019 would increase FDA discretionary funding by $473 million, with much of the additional funding intended to advance the availability of innovative drugs and medical devices and to develop regulatory science tools for reducing opioid-drug misuse and abuse. The funding boost is "a recognition that the agency is doing its job well and making a critical public health difference," said Alliance for a Stronger FDA Executive Director Ladd Wiley.

Full Story: